ApoB/ApoA-1 Ratio as a Novel Prognostic Predictor in Patients With Primary Small Cell Carcinoma of the Esophagus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ApoB/ApoA-1 Ratio as a Novel Prognostic Predictor in Patients With Primary Small Cell Carcinoma of the Esophagus

Published:2020-04-24 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Chen Hao,Chu Ling-Yu,Li Xiao-Hui,Peng Yu-Hui,Liu Can-Tong,Tian Li-Ru,Xie Jian-Jun,Xu Yi-Wei

Funder

Innovative Research Group Project of the National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference43 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Lymph node metastasis and recurrence in primary small cell Carcinoma of the esophagus: a retrospective study of 125 cases;Xu;Cancer Biother Radiopharm,2019

3. Primary small cell carcinoma of the esophagus: clinicopathological study of 44 cases;Chen;BMC Cancer,2014

4. Oat-cell carcinoma of the oesophagus;McKeown;J Pathol Bacteriol,1952

5. Clinical and therapeutic aspects of extrapulmonary small cell carcinoma;Walenkamp;Cancer Treat Rev,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. APOB is a potential prognostic biomarker in hepatocellular carcinoma;Discover Oncology;2024-02-03

2. Potential biomarkers and immune characteristics of small bowel adenocarcinoma;Scientific Reports;2022-09-28

3. Analysis of multiple databases identifies crucial genes correlated with prognosis of hepatocellular carcinoma;Scientific Reports;2022-05-30

4. Circulating Lipid- and Inflammation-Based Risk (CLIR) Score: A Promising New Model for Predicting Outcomes in Complete Colorectal Liver Metastases Resection;Annals of Surgical Oncology;2022-01-04

5. HDL and cancer - causality still needs to be confirmed? Update 2020;Seminars in Cancer Biology;2021-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3